ALBANY MOLECULAR RESH INC's ticker is AMRI and the CUSIP is 012423109. A total of 94 filers reported holding ALBANY MOLECULAR RESH INC in Q2 2013. The put-call ratio across all filers is 1.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $16,106,000 | -16.1% | 1,198,379 | -4.5% | 0.00% | -20.0% |
| Q1 2016 | $19,193,000 | -29.1% | 1,255,264 | -8.0% | 0.01% | -28.6% |
| Q4 2015 | $27,076,000 | +5.0% | 1,364,017 | -7.8% | 0.01% | 0.0% |
| Q3 2015 | $25,784,000 | -21.1% | 1,480,140 | -8.4% | 0.01% | -12.5% |
| Q2 2015 | $32,689,000 | +4.4% | 1,616,646 | -9.1% | 0.01% | 0.0% |
| Q1 2015 | $31,308,000 | +18.6% | 1,778,926 | +9.7% | 0.01% | +14.3% |
| Q4 2014 | $26,401,000 | -3.0% | 1,621,720 | +31.5% | 0.01% | 0.0% |
| Q3 2014 | $27,222,000 | -13.5% | 1,233,431 | -21.2% | 0.01% | -12.5% |
| Q2 2014 | $31,484,000 | +1.0% | 1,564,852 | -6.7% | 0.01% | -11.1% |
| Q1 2014 | $31,167,000 | +9.2% | 1,676,568 | -40.8% | 0.01% | +12.5% |
| Q4 2013 | $28,532,000 | +359.9% | 2,830,500 | +488.1% | 0.01% | +300.0% |
| Q3 2013 | $6,204,000 | +38.9% | 481,300 | +27.9% | 0.00% | +100.0% |
| Q2 2013 | $4,466,000 | – | 376,278 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 567,400 | $11,473,000 | 12.05% |
| Permian Investment Partners, LP | 1,875,650 | $37,926,000 | 7.67% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 1,490,174 | $30,131,000 | 2.57% |
| AMERICAN CAPITAL MANAGEMENT INC | 993,280 | $20,084,000 | 1.91% |
| Netols Asset Management, Inc. | 387,471 | $7,835,000 | 1.54% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,158,759 | $23,430,000 | 1.35% |
| Evercore Wealth Management, LLC | 1,233,880 | $24,948,000 | 1.13% |
| Visium Asset Management, LP | 3,200,000 | $64,704,000 | 0.92% |
| Granite Investment Partners, LLC | 303,787 | $6,143,000 | 0.57% |
| FRANKLIN STREET ADVISORS INC /NC | 144,125 | $2,914,000 | 0.52% |